American Bureau of Drugs Supervision reminds the doctor: It influences the renal function to lower candy medicine one hundred and secrete Damien

American Bureau of Drugs Supervision reminds the doctor: It influences the renal function to lower candy medicine one hundred and secrete Damien
Recently, American Food and Drug Administration (FDA) Remind the medical worker to pay close attention to ending and filling in that peptide (goods name: Byetta, one hundred secretes Damien) Prescription last information,including being cause renal function not to be changed (renal failure and renal functions acute is getting more complete) after listing at medicine Report. It is that one kind is enteric to urge the hormone analog of Langerhans' islits to end and fill in that peptide, for the treatment of adult's 2 type diabetes.
Revise the content to mainly include this time: This medicine is not applied to having serious kidney damaging or end nephropathy patient in latter stages; In kidney being intermediate to damage in the patient, initial administration or dosage should treat cautiously increase 10 to, from 5; When suspecting the patient's renal function is unusual employed this medicine to cause, should monitor its progress with unusual renal function and necessity of using medicine in going on to appraise; Should help the patient to understand the benefit of taking this medicine and danger that can cause the renal function to be unusual. It is reported, FDA had released the warning that this medicine caused the acute pancreatitic risk before this.

|